Literature DB >> 16895956

Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes.

Dominik G Haider1, Johannes Pleiner, Mario Francesconi, Günther F Wiesinger, Markus Müller, Michael Wolzt.   

Abstract

CONTEXT: Exercise training exerts beneficial effects on metabolic and vascular risk factors in patients with type 1 diabetes mellitus (T1DM). It is unknown whether training also influences concentrations of visfatin, a novel insulin-mimetic adipocytokine.
OBJECTIVES: In this study, we have investigated whether plasma visfatin concentrations are altered by training in patients with T1DM. DESIGN AND PATIENTS: Fasting plasma visfatin concentrations and metabolic parameters were measured in 18 patients with T1DM who participated in a supervised aerobic exercise program for 4 months. Three subjects discontinued training prematurely after 2 months. Samples were obtained before and during training and 8 months after the end of regular exercise. Fourteen healthy young subjects served as controls.
RESULTS: At baseline, patients with T1DM had higher visfatin concentrations than controls (64.1 +/- 12.0 vs. 1.3 +/- 0.0 ng/ml, P < 0.01). Exercise reduced visfatin after 2 and 4 months to 27.8 +/- 2.6 (n = 18) and 17.5 +/- 3.4 ng/ml (n = 15), respectively (P < 0.001 for n = 15 subjects who participated in all visits, ANOVA). This effect was maintained 8 months after cessation of training, with visfatin concentrations of 19.7 +/- 5.0 ng/ml (n = 15). Metabolic parameters were not affected by the training program.
CONCLUSION: Elevated visfatin concentrations in patients with T1DM can be lowered by regular physical exercise. It is unknown whether glucose tolerance is affected by changes in visfatin concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895956     DOI: 10.1210/jc.2006-1013

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Nicotinamide Phosphoribosyltransferase in Human Diseases.

Authors:  Li Qin Zhang; Daniel P Heruth; Shui Qing Ye
Journal:  J Bioanal Biomed       Date:  2011-01-07

2.  High-Intensity Exercise and Carbohydrate Supplementation do not Alter Plasma Visfatin.

Authors:  Paul F Mellick; Bryan J Feger; Douglas J Oberlin; Paul G Davis; Laurie Wideman
Journal:  J Sports Sci Med       Date:  2017-03-01       Impact factor: 2.988

3.  Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells.

Authors:  Krishna M Boini; Chun Zhang; Min Xia; Wei-Qing Han; Christopher Brimson; Justin L Poklis; Pin-Lan Li
Journal:  Biochim Biophys Acta       Date:  2010-09-19

4.  Inflammation, a link between obesity and cardiovascular disease.

Authors:  Zhaoxia Wang; Tomohiro Nakayama
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

5.  Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.

Authors:  M Ozkaya; M Sahin; E Cakal; F Yuzbasioglu; K Sezer; M Kilinc; S Simsek Imrek
Journal:  J Endocrinol Invest       Date:  2009-05-15       Impact factor: 4.256

Review 6.  Adipokines: Biomarkers for osteoarthritis?

Authors:  Thitiya Poonpet; Sittisak Honsawek
Journal:  World J Orthop       Date:  2014-07-18

7.  Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Francesca Gotsch; Pooja Mittal; Nandor Gabor Than; Chia-Lang Nhan-Chang; Neil Hamill; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Samuel S Edwin; Jyh Kae Nien; Ricardo Gomez; Jimmy Espinoza; Claire Kendal-Wright; Sonia S Hassan; Gillian Bryant-Greenwood
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

Review 8.  What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review.

Authors:  M Chimen; A Kennedy; K Nirantharakumar; T T Pang; R Andrews; P Narendran
Journal:  Diabetologia       Date:  2011-12-22       Impact factor: 10.122

9.  The novel adipocytokine visfatin exerts direct cardioprotective effects.

Authors:  Shiang Y Lim; Sean M Davidson; Ajeev J Paramanathan; Christopher C T Smith; Derek M Yellon; Derek J Hausenloy
Journal:  J Cell Mol Med       Date:  2008-04-08       Impact factor: 5.310

Review 10.  Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?

Authors:  Jaswinder K Sethi
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.